CIK: 1356256 - Address: C/O Harpoon Therapeutics, Inc., 611 Gateway Boulevard, Suite 400, South San Francisco, CA 94080
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret115361227-2604
P%wins80100100100076

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/12/23 19:05
4/12/23
VRDNViridian Therapeutics, Inc.deDEHealthHealthMedical LaboratoriesMyers Scott DunsethMADOCEOP10125.37042260D
3/13/23 16:06
3/13/23
VRDNViridian Therapeutics, Inc.deDEHealthHealthMedical LaboratoriesMyers Scott DunsethMADOCEOP16029.15062256D
1/16/18 17:26
1/11/18
CASCCascadian Therapeutics, Inc.DEHealthBiolabCommercial Physical & BiologiMyers Scott DunsethWADOP,CEOM.d00.000112357D
8/14/17 17:12
8/11/17
CASCCascadian Therapeutics, Inc.DEHealthBiolabCommercial Physical & BiologiMyers Scott DunsethWADOP,CEOP213.74061250D
5/16/17 17:43
5/12/17
CASCCascadian Therapeutics, Inc.DEHealthBiolabCommercial Physical & BiologiMyers Scott DunsethWADOP,CEOP114.0013744D-53-32-36110-27
4/4/17 17:39
3/31/17
CASCCascadian Therapeutics, Inc.DEHealthBiolabCommercial Physical & BiologiMyers Scott DunsethWADOP,CEOP84.1112541D-59-43-59-7-7-33-3-319
3/21/17 20:09
3/20/17
CASCCascadian Therapeutics, Inc.DEHealthBiolabCommercial Physical & BiologiMyers Scott DunsethWADOP,CEOP43.9311339D-63-49-49-25-12-8-6-27138
1/31/17 16:55
1/27/17
CASCCascadian Therapeutics, Inc.DEHealthBiolabCommercial Physical & BiologiMyers Scott DunsethWADOP,CEOP773.7622111438D-56-47-37-38-20-1611112733
8/18/16 17:16
8/17/16
CASCCascadian Therapeutics, Inc.DEHealthBiolabCommercial Physical & BiologiMyers Scott DunsethWADOP,CEOP521.1504572108D-60-658-22013412120-38
6/28/16 17:36
6/28/16
CASCCascadian Therapeutics, Inc.DEHealthBiolabCommercial Physical & BiologiMyers Scott DunsethWADOP,CEOP500.8000263New63D-74-77-64-21-20-26-102952677-13
5/26/06 13:50
5/24/06
DOVPDov Pharmaceutical IncDEHealthDrugPharmaceutical PreparationsMyers Scott DunsethNJOSVPP.m272.69010New10

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact